Andreas Laupacis

14.1k total citations · 5 hit papers
98 papers, 9.7k citations indexed

About

Andreas Laupacis is a scholar working on Cardiology and Cardiovascular Medicine, Economics and Econometrics and Surgery. According to data from OpenAlex, Andreas Laupacis has authored 98 papers receiving a total of 9.7k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Cardiology and Cardiovascular Medicine, 26 papers in Economics and Econometrics and 18 papers in Surgery. Recurrent topics in Andreas Laupacis's work include Health Systems, Economic Evaluations, Quality of Life (26 papers), Atrial Fibrillation Management and Outcomes (18 papers) and Antiplatelet Therapy and Cardiovascular Diseases (12 papers). Andreas Laupacis is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (26 papers), Atrial Fibrillation Management and Outcomes (18 papers) and Antiplatelet Therapy and Cardiovascular Diseases (12 papers). Andreas Laupacis collaborates with scholars based in Canada, United States and United Kingdom. Andreas Laupacis's co-authors include Robin S. Roberts, David L. Sackett, Malcolm Man‐Son‐Hing, Michael Gent, Paul Keown, Campbell Joyner, John A. Cairns, Stuart J. Connolly, Carl van Walraven and Peter Tugwell and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

Andreas Laupacis

96 papers receiving 9.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An Assessment of Clinically Useful Measures of the Consequences of Treatment

1988 1.2k citations Andreas Laupacis, David L. Sackett et al. New England Journal of Medicine profile →
Canadian atrial fibrillation anticoaguiation (CAFA) study

1991 831 citations Stuart J. Connolly, Andreas Laupacis et al. Journal of the American College of Cardiology profile →
Oral Anticoagulants vs Aspirin in Nonvalvular Atrial Fibrillation

2002 534 citations Andreas Laupacis et al. profile →
The effect of elective total hip replacement on health-related quality of life.

1993 511 citations Andreas Laupacis, Peter Tugwell et al. profile →
Effects of Cyclosporine Immunosuppression in Insulin-Dependent Diabetes Mellitus of Recent Onset

1984 428 citations C. R. Stiller, John Dupré et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andreas Laupacis Canada	48	3.2k	2.1k	1.5k	1.4k	1.1k	98	9.7k
Jodi B Segal United States	59	2.0k 0.6×	2.1k 1.0×	1.5k 1.0×	982 0.7×	1.5k 1.4×	247	12.4k
Andreas Laupacis Canada	52	3.7k 1.1×	1.6k 0.8×	1.3k 0.9×	1.2k 0.9×	564 0.5×	120	10.2k
Morten Schmidt Denmark	44	4.3k 1.3×	2.9k 1.4×	2.6k 1.8×	779 0.5×	920 0.9×	201	14.3k
Wolfgang C. Winkelmayer United States	59	3.0k 0.9×	1.9k 0.9×	1.1k 0.7×	1.4k 1.0×	518 0.5×	364	12.5k
Per Olav Vandvik Norway	55	2.7k 0.8×	2.7k 1.3×	2.1k 1.4×	934 0.7×	1.7k 1.6×	179	11.9k
Alfonso Iorio Canada	57	3.9k 1.2×	2.0k 1.0×	1.7k 1.2×	1.0k 0.7×	3.0k 2.9×	416	16.2k
Lynne T. Braun United States	32	4.4k 1.4×	2.0k 0.9×	2.1k 1.4×	680 0.5×	261 0.2×	106	9.6k
Rajiv Saran United States	58	2.4k 0.7×	2.1k 1.0×	1.5k 1.0×	936 0.7×	295 0.3×	189	13.9k
Thomas E. Feasby Canada	35	2.1k 0.7×	2.4k 1.1×	2.8k 1.9×	1.1k 0.7×	313 0.3×	80	13.0k
Nicolas Rodondi Switzerland	54	3.2k 1.0×	1.7k 0.8×	1.2k 0.8×	1.2k 0.9×	524 0.5×	397	10.7k

Countries citing papers authored by Andreas Laupacis

Since Specialization

Citations

This map shows the geographic impact of Andreas Laupacis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Laupacis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Laupacis more than expected).

Fields of papers citing papers by Andreas Laupacis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Laupacis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Laupacis. The network helps show where Andreas Laupacis may publish in the future.

Co-authorship network of co-authors of Andreas Laupacis

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Laupacis. A scholar is included among the top collaborators of Andreas Laupacis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Laupacis. Andreas Laupacis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Persaud, Navindra, Amir Azarpazhooh, Charles Keown‐Stoneman, et al.. (2023). Xylitol for the prevention of acute otitis media episodes in children aged 1–5 years: a randomised controlled trial. Archives of Disease in Childhood. 109(2). 121–124.

Wijeysundera, Duminda N., W. Scott Beattie, Keyvan Karkouti, et al.. (2011). Association of echocardiography before major elective non-cardiac surgery with postoperative survival and length of hospital stay: population based cohort study. BMJ. 342(jun30 1). d3695–d3695. 80 indexed citations

Fischer, Hadas D., David N. Juurlink, Muhammad Mamdani, Alexander Kopp, & Andreas Laupacis. (2010). Hemorrhage During Warfarin Therapy Associated With Cotrimoxazole and Other Urinary Tract Anti-infective Agents. Archives of Internal Medicine. 170(7). 617–21. 48 indexed citations

Choudhry, Niteesh K., Brandon Zagorski, Jerry Avorn, et al.. (2008). Comparison of the Impact of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management Trial on Prescribing Patterns: A Time-Series Analysis. Annals of Pharmacotherapy. 42(11). 1563–1572. 12 indexed citations

Paterson, J. Michael, Greg Carney, George Anderson, et al.. (2006). Case selection for statins was similar in two Canadian provinces: BC and Ontario. Journal of Clinical Epidemiology. 60(1). 73–78. 1 indexed citations

Parshuram, Christopher S., L. Lee Dupuis, Teresa To, et al.. (2006). Medication Safety: Occurrence and Impact of Unanticipated Variation in Intravenous Methotrexate Dosing. Annals of Pharmacotherapy. 40(5). 805–811. 10 indexed citations

Manuel, Douglas G., Kelvin Kwong, Peter Tanuseputro, et al.. (2006). Effectiveness and efficiency of different guidelines on statin treatment for preventing deaths from coronary heart disease: modelling study. BMJ. 332(7555). 1419–1419. 67 indexed citations

Mamdani, Muhammad, David N. Juurlink, Alex Kopp, et al.. (2004). Gastrointestinal bleeding after the introduction of COX 2 inhibitors: ecological study. BMJ. 328(7453). 1415–1416. 75 indexed citations

O’Connor, Annette M., Elizabeth Drake, George A. Wells, et al.. (2003). A survey of the decision‐making needs of Canadians faced with complex health decisions. Health Expectations. 6(2). 97–109. 108 indexed citations

10.

Man‐Son‐Hing, Malcolm, et al.. (2002). Determination of the clinical importance of study results. Journal of General Internal Medicine. 17(6). 469–476. 128 indexed citations

11.

Laupacis, Andreas. (2002). The Cochrane Collaboration – how is it progressing?. Statistics in Medicine. 21(19). 2815–2822. 6 indexed citations

12.

Hutchinson, Angela B., Dean Fergusson, Ian D. Graham, et al.. (2001). Utilization of technologies to reduce allogeneic blood transfusion in the United States. Transfusion Medicine. 11(2). 79–85. 30 indexed citations

13.

O’Connor, Annette M., George A. Wells, Peter Tugwell, et al.. (1999). The effects of an `explicit' values clarification exercise in a woman's decision aid regarding postmenopausal hormone therapy. Health Expectations. 2(1). 21–32. 67 indexed citations

14.

Fergusson, Dean, et al.. (1998). Adverse effects of methods for minimizing perioperative allogeneic transfusion: A critical review of the literature. Transfusion Medicine Reviews. 12(3). 206–225. 64 indexed citations

15.

Laupacis, Andreas & Katherine J. Sullivan. (1996). Canadian atrial fibrillation anticoagulation study: were the patients subsequently treated with warfarin? Canadian Atrial Fibrillation Anticoagulation Study Group.. PubMed. 154(11). 1669–74. 7 indexed citations

16.

Laupacis, Andreas, Gregory W. Albers, James E. Dalen, et al.. (1995). Antithrombotic Therapy in Atrial Fibrillation. CHEST Journal. 108(4). 352S–359S. 156 indexed citations

17.

Connolly, Stuart J., Andreas Laupacis, Michael Gent, et al.. (1991). Canadian atrial fibrillation anticoaguiation (CAFA) study. Journal of the American College of Cardiology. 18(2). 349–355. 831 indexed citations breakdown →

18.

Laupacis, Andreas, David L. Sackett, & Robin S. Roberts. (1988). An Assessment of Clinically Useful Measures of the Consequences of Treatment. New England Journal of Medicine. 318(26). 1728–1733. 1226 indexed citations breakdown →

19.

Stiller, C. R., John Dupré, Michael Gent, et al.. (1987). Effects of cyclosporine in recent-onset juvenile type 1 diabetes: Impact of age and duration of disease. The Journal of Pediatrics. 111(6). 1069–1072. 20 indexed citations

20.

Smit, J. A., et al.. (1983). RENAL ALLOGRAFT SURVIVAL IN THE BABOON USING A PRETREATMENT PROTOCOL WITH CYCLOSPORINE. Transplantation. 36(2). 121–124. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact